Clinical Trials Directory

Trials / Conditions / Recurrent Gallbladder Carcinoma

Recurrent Gallbladder Carcinoma

7 registered clinical trials studyying Recurrent Gallbladder Carcinoma.

StatusTrialSponsorPhase
Active Not RecruitingStudy of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A Co
NCT05564403
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTesting A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or With
NCT04941287
National Cancer Institute (NCI)Phase 2
Active Not RecruitingGuadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder C
NCT03257761
University of Southern CaliforniaPhase 1
Active Not RecruitingRecombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or
NCT02495896
University of Southern CaliforniaPhase 1
CompletedTrametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder
NCT02042443
National Cancer Institute (NCI)Phase 2
CompletedMK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery
NCT01425879
National Cancer Institute (NCI)Phase 2
CompletedSorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Me
NCT01093222
National Cancer Institute (NCI)Phase 2